199 related articles for article (PubMed ID: 12104042)
1. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.
Lu S; Zhang X; Badawi AF; El-Sohemy A; Archer MC
Cancer Lett; 2002 Oct; 184(1):7-12. PubMed ID: 12104042
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
Badawi AF; Eldeen MB; Liu Y; Ross EA; Badr MZ
Cancer Res; 2004 Feb; 64(3):1181-9. PubMed ID: 14871855
[TBL] [Abstract][Full Text] [Related]
5. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
Alshafie GA; Abou-Issa HM; Seibert K; Harris RE
Oncol Rep; 2000; 7(6):1377-81. PubMed ID: 11032948
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats.
Kubatka P; Kalická K; Chamilová M; Ahlersová E; Ahlers I; Bojková B; Adámeková E
Neoplasma; 2002; 49(4):255-9. PubMed ID: 12382025
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
11. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands.
Badawi AF; El-Sohemy A; Stephen LL; Ghoshal AK; Archer MC
Carcinogenesis; 1998 May; 19(5):905-10. PubMed ID: 9635881
[TBL] [Abstract][Full Text] [Related]
12. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
14. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
16. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib and melatonin in prevention of female rat mammary carcinogenesis.
Orendas P; Kassayova M; Kajo K; Ahlers I; Kubatka P; Bojkova B; Pec M; Ahlersova E
Neoplasma; 2009; 56(3):252-8. PubMed ID: 19309229
[TBL] [Abstract][Full Text] [Related]
18. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid.
Yuri T; Danbara N; Tsujita-Kyutoku M; Fukunaga K; Takada H; Inoue Y; Hada T; Tsubura A
Nutr Cancer; 2003; 45(2):211-7. PubMed ID: 12881016
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.
Matsunaga K; Yoshimi N; Yamada Y; Shimizu M; Kawabata K; Ozawa Y; Hara A; Mori H
Jpn J Cancer Res; 1998 May; 89(5):496-501. PubMed ID: 9685852
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.
Nakatsugi S; Ohta T; Kawamori T; Mutoh M; Tanigawa T; Watanabe K; Sugie S; Sugimura T; Wakabayashi K
Jpn J Cancer Res; 2000 Sep; 91(9):886-92. PubMed ID: 11011115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]